JC Virus T-Antigen DNA in gastrointestinal mucosa of immunosuppressed patients: A prospective, controlled study

Keyphrases

• Prospective Controlled Study 100%
• Immunocompromised Patients 100%
• Intestinal mucosa 100%
• T Antigen 100%
• JC Virus 100%
• Inflammatory Bowel Disease 44%
• High Prevalence 33%
• Upper Gastrointestinal Tract 22%
• Lower Gastrointestinal Tract 22%
• Immunosuppression 11%
• Immunosuppressive Drugs 11%
• Colonic Polyps 11%
• Virus 11%
• Progressive multifocal Leukoencephalopathy 11%
• Oncogenic Potential 11%
• Noninflammatory 11%
• Disease Case 11%
• Transplant Recipients 11%
• Etiological Agents 11%
• Gastrointestinal Carcinoma 11%
• Polymerase Chain Reaction 11%
• Colon Adenocarcinoma 11%
• Polyomavirus 11%

Medicine and Dentistry

• JC Virus 100%
• Virus T Antigen 100%
• Gastrointestinal Mucosa 100%
• Prevalence 44%
• Inflammatory Bowel Disease 22%
• Patient with Inflammatory Bowel Disease 22%
• Immunosuppressive Drug 11%
• Polymerase Chain Reaction 11%
• Colon Polyp 11%
• Progressive Multifocal Leukoencephalopathy 11%
• Polyomavirus 11%
• Gastrointestinal Carcinoma 11%
• Colon Carcinoma 11%
• Immunosuppressive Treatment 11%
• Transplantation 11%

Immunology and Microbiology

• JC Virus 100%
• Gastrointestinal Mucosa 100%
• Virus T Antigen 100%
• Prevalence 44%
• Inflammatory Bowel Disease 44%
• Immunosuppression 11%
• Immunosuppressive Drug 11%
• Transplant Procedure 11%
• Polyomavirus 11%
• Polymerase Chain Reaction 11%